Treatment satisfaction in patients with type 2 diabetes is significantly improved with liraglutide, the once-daily GLP-1 analogue versus sitagliptin, both combined with metformin

被引：0
|
作者：
Montanya Mias, E. [1 ]
Cuddihy, R. [2 ]
Pratley, R. [3 ]
Hammer, M. [4 ]
Thomsen, A. [4 ]
Davies, M. J. [5 ]
机构：
[1] IDIBELL Hosp Univ Bellvitge, Barcelona, Spain
[2] Int Diabet Ctr, Minneapolis, MN USA
[3] Univ Vermont, Burlington, VT 05405 USA
[4] Novo Nordisk AS, Soborg, Denmark
[5] Univ Leicester, Leicester LE1 7RH, Leics, England
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
832
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Sitagliptin and metformin increase active GLP-1 by complementary mechanisms in treatment-naive patients with type 2 diabetes
    Migoya, E. M.
    Miller, J.
    Luo, W. -L.
    O'Neill, E.
    Morrow, L.
    Gutierrez, M. J.
    Stoch, A.
    Wagner, J. A.
    DIABETOLOGIA, 2010, 53
  • [42] Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes
    Lee, Byung-Wan
    Cho, Young Min
    Kim, Sin Gon
    Ko, Seung-Hyun
    Lim, Soo
    Dahaoui, Amine
    Jeong, Jin Sook
    Lim, Hyo Jin
    Yu, Jae Myung
    DIABETES THERAPY, 2024, 15 (02) : 547 - 563
  • [43] Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
    Vilsboll, T.
    Brock, B.
    Perrild, H.
    Levin, K.
    Lervang, H. -H.
    Kolendorf, K.
    Krarup, T.
    Schmitz, O.
    Zdravkovic, M.
    Le-Thi, T.
    Madsbad, S.
    DIABETIC MEDICINE, 2008, 25 (02) : 152 - 156
  • [44] The Effective Switch from Intensive Insulin Therapy to the Once-Daily GLP-1 Analogue Liraglutide in Patients with Fairly Well Controlled (HbA1c, 5.1-7.5%) Type 2 Diabetes
    Kikuchi, Taisuke
    Terauchi, Yasuo
    DIABETES, 2011, 60 : A622 - A622
  • [45] Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes
    Byung-Wan Lee
    Young Min Cho
    Sin Gon Kim
    Seung-Hyun Ko
    Soo Lim
    Amine Dahaoui
    Jin Sook Jeong
    Hyo Jin Lim
    Jae Myung Yu
    Diabetes Therapy, 2024, 15 : 547 - 563
  • [46] Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes
    Hanefeld, Markolf
    Herman, Gary A.
    Wu, Mei
    Mickel, Carolyn
    Sanchez, Matilde
    Stein, Peter P.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (06) : 1329 - 1339
  • [47] The once-daily human GLP-1 analog liraglutide reduces body weight in subjects with type 2 diabetes, irrespective of body mass index at baseline
    Russell-Jones, David
    Shaw, Jonathan E.
    Brandle, Michael
    Matthews, David
    Frid, Anders
    Zdravkovic, Milan
    Schmitz, Ole
    DIABETES, 2008, 57 : A593 - A594
  • [48] Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
    Qiao, Qing
    Ouwens, Mario J. N. M.
    Grandy, Susan
    Johnsson, Kristina
    Kostev, Karel
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 201 - 205
  • [49] Liraglutide: A once-daily human glucagon-like peptide-1 analogue for type 2 diabetes mellitus
    Joffe, David
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (16) : 1326 - 1336
  • [50] GLP-1 analogue liraglutide as adjunct treatment in diabetes type 2 after failed bariatric/metabolic surgery
    Hellstrom, Per M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
12345